Tuesday, November 11, 2025 | 06:55 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts

Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest

doctors, clinic, drugs, pharma, medicine, generic, patients, hospitals
premium

Avdhut Bagkar Mumbai
Dr. Lal Path Labs Ltd (LALPATHLAB): The stock is quite stable above the 200-days moving average (DMA) though has not been able to show a strong positive move off-late. The bigger picture illustrates a strong selling pressure above Rs 1,700 levels and is likely to sideways for now, as per the daily chart. The support remains at Rs 1,521, which is its 200-DMA. CLICK HERE FOR THE CHART

Metropolis Healthcare Ltd (METROPOLIS):  The daily chart clearly indicates a resistance at 100-DMA located at Rs 1,471 levels. The support remains at 200-DMA, placed